Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06431438
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Brief Title:
Study to Evaluate the Tolerability Safety Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A Phase I Clinical Trial to Evaluate the Tolerability Safety Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was a single-center study including randomized double-blind placebo-controlled single-dose escalation study multiple-dose study food effect on pharmacokinetics and drug metabolism transformation study drug interaction study To evaluate the tolerability pharmacokinetics and metabolic transformation of TQA3810 in healthy subjects after single or multiple doses of TQA3810 the drug-drug interactions between TQA3810 tablets and entecavir dispersible tablets and the pharmacokinetic properties of TQA3810 tablets in combination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None